Histamine release – hypotension, reflex tachycardia and cutaneous flush Bronchospasm – Pulmonary compliance To date,<unk>  has not been reported to elicit bronchospasm at doses that are clinically prescribed. Laudanosine – Epileptic foci<unk>  undergoes Hofmann elimination as a primary route of chemodegradation: consequently one of the metabolites from this process is laudanosine, a tertiary amino alkaloid reported to be a modest CNS stimulant with epileptogenic activity and cardiovascular effects such as low blood pressure and a slowed heart rate. As a tertiary amine, Laudanosine is unionised and readily crosses the blood–brain barrier. Presently, there is little evidence that laudanosine accumulation and related toxicity will likely ever be seen with the doses of<unk>  that are administered in clinical practice especially given that the plasma concentrations of laudanosine generated are lower with<unk>  than those seen with atracurium.
Cisatracurium besilate
Mivacurium chloride
Gantacurium chloride
Atracurium besilate
Suxamethonium chloride
Pancuronium bromide
Rapacuronium bromide
Rocuronium bromide